financetom
Business
financetom
/
Business
/
Connexa Sports Shareholders Approve Yuanyu Enterprise Acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Connexa Sports Shareholders Approve Yuanyu Enterprise Acquisition
May 17, 2024 10:08 AM

12:39 PM EDT, 05/17/2024 (MT Newswires) -- Connexa Sports Technologies ( YYAI ) said Friday its shareholders have approved the acquisition of Yuanyu Enterprise Management at a meeting on May 15.

Pending Nasdaq approval of a change of control, Hongyu Zhou, the sole shareholder of Yuanyu, will own a controlling interest in Connexa, the company said.

Price: 0.82, Change: -0.01, Percent Change: -0.72

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US dependence on Canada's oil should deter Trump tariffs, industry says
US dependence on Canada's oil should deter Trump tariffs, industry says
Nov 12, 2024
* Most of Canada's 4 million bpd of oil exports to go U.S. * U.S. cannot easily replace Canadian barrels * Stronger U.S. dollar could benefit Canadian producers, says analyst By Nia Williams Nov 12 (Reuters) - Canada's energy industry does not expect U.S. President-elect Donald Trump's broad plans for protectionist trade measures will include tariffs on Canadian oil imports,...
Nuvalent's Q3 Net Loss Widens
Nuvalent's Q3 Net Loss Widens
Nov 12, 2024
06:53 AM EST, 11/12/2024 (MT Newswires) -- Nuvalent ( NUVL ) reported a Q3 net loss Tuesday of $1.28 per diluted share, widening from a loss of $0.59 a year earlier. Analysts polled by Capital IQ expected a loss of $0.93. The clinical-stage biopharmaceutical company did not report any revenue for the quarter ended Sept. 30. ...
Roivant Sciences' Fiscal Q2 Net Loss Narrows, Revenue Rises
Roivant Sciences' Fiscal Q2 Net Loss Narrows, Revenue Rises
Nov 12, 2024
07:45 AM EST, 11/12/2024 (MT Newswires) -- Roivant Sciences ( ROIV ) reported a fiscal Q2 net loss Tuesday of $0.31 per diluted share, narrowing from a loss of $0.40 a year earlier. Analysts polled by Capital IQ expected a loss of $0.27. Net revenue for the quarter ended Sept. 30 was $4.5 million, up from $3.6 million a year...
Neumora Therapeutics Q3 Loss Narrows
Neumora Therapeutics Q3 Loss Narrows
Nov 12, 2024
07:31 AM EST, 11/12/2024 (MT Newswires) -- Neumora Therapeutics ( NMRA ) reported a Q3 loss Tuesday of $0.45 per diluted share, narrower than the loss of $1.14 a year earlier. Analysts polled by Capital IQ expected a loss of $0.39. The clinical-stage biopharmaceutical company did not report any revenue for the quarter ended Sept. 30. Neumora said it had...
Copyright 2023-2026 - www.financetom.com All Rights Reserved